Medical World News® Deep Dive: Mehmet Sitki Copur, MD, on the Potential of mRNA Vaccines in Cancer Immunotherapy

Tumor Board | <b>Mehmet Sitki Copur, MD, FACP</b>

Copur spoke with CancerNetwork® about the potential for a new era of cancer treatment and immunotherapy with the recent approval of mRNA vaccines to treat COVID-19.

CancerNetwork® sat down with Mehmet Sitki Copur, MD, Medical Director of Oncology, Medical Oncology/Hematology Mary Lanning Healthcare Morrison Cancer Center and Professor, University of Nebraska Medical Center, to discuss his article in the journal ONCOLOGY®, titled “Messenger RNA Vaccines-Beckoning of a New Era in Cancer Immunotherapy.”

Copur discussed how the approval of recent messenger RNA (mRNA) vaccines by the FDA to combat COVID-19 opens a door for the potential future of cancer immunotherapy and mRNA vaccines.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.